Anton D. Michel

3.2k total citations · 1 hit paper
55 papers, 2.6k citations indexed

About

Anton D. Michel is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Anton D. Michel has authored 55 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 22 papers in Cellular and Molecular Neuroscience and 16 papers in Physiology. Recurrent topics in Anton D. Michel's work include Receptor Mechanisms and Signaling (21 papers), Adenosine and Purinergic Signaling (16 papers) and Neuropeptides and Animal Physiology (14 papers). Anton D. Michel is often cited by papers focused on Receptor Mechanisms and Signaling (21 papers), Adenosine and Purinergic Signaling (16 papers) and Neuropeptides and Animal Physiology (14 papers). Anton D. Michel collaborates with scholars based in United Kingdom, Poland and United States. Anton D. Michel's co-authors include R.L. Whiting, Dana N. Loury, P.P.A. Humphrey, Iain P. Chessell, Gary Buell, Jill Richardson, C. Bountra, Caroline Grahames, Julie Egerton and Jane P. Hughes and has published in prestigious journals such as Journal of Biological Chemistry, Pain and Journal of Medicinal Chemistry.

In The Last Decade

Anton D. Michel

53 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain

2005 668 citations Iain P. Chessell, Jonathan P. Hatcher et al. Pain profile →

Peers

Countries citing papers authored by Anton D. Michel

Since Specialization

Citations

This map shows the geographic impact of Anton D. Michel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anton D. Michel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anton D. Michel more than expected).

Fields of papers citing papers by Anton D. Michel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anton D. Michel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anton D. Michel. The network helps show where Anton D. Michel may publish in the future.

Co-authorship network of co-authors of Anton D. Michel

This figure shows the co-authorship network connecting the top 25 collaborators of Anton D. Michel. A scholar is included among the top collaborators of Anton D. Michel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anton D. Michel. Anton D. Michel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A novel series of benzimidazole NR2B-selective NMDA receptor antagonists 2012 ·Bioorganic & Medicinal Chemistry Letters ·D.J.G. Davies, (unknown), Nolwenn Lucas, (unknown), David D. Miller, (unknown), (unknown), Ezio Bettini, (unknown), Caterina Virginio, (unknown), Paul Goldsmith, Anton D. Michel, Iain P. Chessell, James N.C. Kew, Neil D. Miller, Martin J. Gunthorpe	14
2	Synthesis and structure–activity relationships of a series of (1H-pyrazol-4-yl)acetamide antagonists of the P2X7 receptor 2010 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Alexander J. Stevens, (unknown), Anton D. Michel, Daryl S. Walter, D.J.G. Davies, David G. Livermore, Elena Fonfría, Emmanuel H. Demont, (unknown), Pam Theobald, Paul Beswick, Robert J. Gleave, Shilina Roman, Stefan Senger	21
3	Identification of 2-oxo-N-(phenylmethyl)-4-imidazolidinecarboxamide antagonists of the P2X7 receptor 2010 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Paul Beswick, Andy Billinton, (unknown), David K. Dean, Elena Fonfría, Robert J. Gleave, Stephen J. Medhurst, Anton D. Michel, (unknown), Sadhana Patel, Shilina Roman, Tiziana Scoccitti, Beverley Smith, Jon G.A. Steadman, Daryl S. Walter	25
4	Mechanism of action of species‐selective P2X₇receptor antagonists 2009 ·British Journal of Pharmacology ·Anton D. Michel, (unknown), Shilina Roman, William C. Clay, David K. Dean, Daryl S. Walter	52
5	1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists: Structure–activity relationships of 4- and 5-substituted benzoic acid derivatives 2006 ·Bioorganic & Medicinal Chemistry Letters ·Adrian Hall, Susan H. Brown, Iain P. Chessell, A. R. Chowdhury, (unknown), Tanya Coleman, Gerard M.P. Giblin, Beverley Hammond, Mark P. Healy, Matthew R. Johnson, (unknown), Anton D. Michel, Alan Naylor, Riccardo Novelli, David J. Spalding, (unknown)	9
6	Structure–activity relationships of 1,5-biaryl pyrroles as EP1 receptor antagonists 2006 ·Bioorganic & Medicinal Chemistry Letters ·Adrian Hall, Stephen J. Atkinson, Susan H. Brown, Iain P. Chessell, A. R. Chowdhury, (unknown), Tanya Coleman, Gerard M.P. Giblin, Robert J. Gleave, Beverley Hammond, Mark P. Healy, Matthew R. Johnson, Anton D. Michel, Alan Naylor, Riccardo Novelli, David J. Spalding, (unknown)	21
7	Discovery of novel biaryl heterocyclic EP1 receptor antagonists 2006 ·Bioorganic & Medicinal Chemistry Letters ·Adrian Hall, Rino A. Bit, Susan H. Brown, (unknown), Iain P. Chessell, Tanya Coleman, Gerard M.P. Giblin, David N. Hurst, (unknown), Xiao Qing Lewell, Anton D. Michel, (unknown), Alan Naylor, Riccardo Novelli, (unknown), David J. Spalding, (unknown), Richard J. Wilson	16
8	Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain breakdown → 2005 ·Pain ·Iain P. Chessell, Jonathan P. Hatcher, C. Bountra, Anton D. Michel, Jane P. Hughes, (unknown), Julie Egerton, (unknown), Jill Richardson, (unknown), Caroline Grahames, (unknown), Y. Yiangou, Rolfe Birch, Praveen Anand, Gary Buell	668
9	Activation of adenylate cyclase by human recombinant sst₅ receptors expressed in CHO‐K1 cells and involvement of G_αs proteins 1999 ·British Journal of Pharmacology ·Alan Carruthers, (unknown), Anton D. Michel, W. Feniuk, P.P.A. Humphrey	34
10	High affinity P_2x‐purinoceptor binding sites for [³⁵S]‐adenosine 5′‐0‐[3‐thiotriphosphate] in rat vas deferens membranes 1996 ·British Journal of Pharmacology ·Anton D. Michel, P.P.A. Humphrey	12
11	The binding characteristics of a human bladder recombinant P_2X purinoceptor, labelled with [³H]‐αβmeATP, [³⁵S]‐ATPγS or ³³[P]‐ATP 1996 ·British Journal of Pharmacology ·Anton D. Michel, Kenneth Lundström, Gary Buell, Annmarie Surprenant, Soledad Valera, P.P.A. Humphrey	29
12	P2 purinoceptor antagonist properties of pyridoxal-5-phosphate 1994 ·European Journal of Pharmacology ·Derek J. Trezise, (unknown), Baljit S. Khakh, Anton D. Michel, (unknown), Peter A. Humphrey	41
13	Characterization of the binding of [³H]‐l‐N^G‐nitro‐arginine in rat brain 1993 ·British Journal of Pharmacology ·Anton D. Michel, (unknown), Tracy L. Stewart, P.P.A. Humphrey	30
14	In vivo occupancy of histamine H3 receptors by thioperamide and (R)-α-methylhistamine measured using histamine turnover and an ex vivo labeling technique 1992 ·Biochemical Pharmacology ·S. Taylor, Anton D. Michel, Gavin J. Kilpatrick	38
15	Induction of the angiotensin AT2 receptor subtype expression by differentiation of the neuroblastoma × glioma hybrid, NG-108-15 1992 ·European Journal of Pharmacology Molecular Pharmacology ·Susan E. Bryson, Philip Warburton, (unknown), G.M. Drew, Anton D. Michel, Stephen G. Ball, Anthony J. Balmforth	14
16	On the interaction of gallamine with muscarinic receptor subtypes 1990 ·European Journal of Pharmacology ·Anton D. Michel, (unknown), (unknown), R.L. Whiting	32
17	Assessment of imiloxan as a selective α_2B‐adrenoceptor antagonist 1990 ·British Journal of Pharmacology ·Anton D. Michel, Dana N. Loury, R.L. Whiting	42
18	Direct labeling of rat M3-muscarinic receptors by [3H]4DAMP 1989 ·European Journal of Pharmacology ·Anton D. Michel, Eric Stefanich, R.L. Whiting	107
19	Synthesis and Pharmacological Evaluation of N,N-di-n-Propyldopamine Congeners Containing Phenolic Bioisosteres 1987 ·Journal of Pharmaceutical Sciences ·Robin D. Clark, Joan M. Caroon, Nancy E. Isaac, (unknown), Anton D. Michel, (unknown), Roberto P. Rosenkranz, L. David Waterbury	8
20	Die Sentenzen des Kardinals Humbert : das erste Rechtsbuch der päpstlichen Reform 1952 ·Anton D. Michel	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact